Skip to main content
Screener/Healthcare/Biotechnology

UTHR — United Therapeutics Corporation

NASDAQ
$564.56-4.64 (-0.82%)
Large CapHealthcareLow BetaMost Profitable
$272.12
$609.35
$561.20
$573.52
EPS (TTM)$27.86
P/E Ratio20.26
Dividend Yield—
Market Cap$24.95B
Volume256K
Prev Close$569.18
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$790.2M$364.3M$7.6686.9%46.1%
Q3 '25$799.5M$338.7M$7.1687.4%42.4%
Q2 '25$798.6M$309.5M$6.4189.0%38.8%
Q1 '25$794.4M$322.2M$6.6388.4%40.6%
Q4 '24$735.9M$301.3M$6.1989.7%40.9%
Q3 '24$748.9M$309.1M$6.3988.9%41.3%
Q2 '24$714.9M$278.1M$5.8589.1%38.9%
Q1 '24$677.7M$306.6M$6.1789.2%45.2%
Get Your Daily Market Recap